1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > US Diagnostic Market Outlook 2020

US Diagnostic Market Outlook 2020

  • September 2015
  • -
  • RNCOS
  • -
  • 90 pages

Diagnostic products and services in the US have been witnessing a steady demand over the past few years, backed by an increase in the insured population under Public Protection and Affordable Care Act, increasing awareness about early disease detection, increasing chronic diseases and an ever increasing aging population.

The US diagnostic market accounts for a major portion of the country’s total healthcare market. The market growth is expected to grow in the coming years mainly due to segments, such as oncology, molecular diagnostics, point-of-care testing, personalized medicine and the associated companion diagnostics.

According to our research report, “US Diagnostic Market Outlook 2020”, the US represents the world’s largest and most matured diagnostic markets. Despite economic challenges and changes in the market environment in the wake of Patient Protection and Affordable Care Act, the US Diagnostics market has experienced a steady growth over the past few years. Looking ahead, the US market for diagnostic products is expected to slow down as the emerging markets offer a more lucrative business opportunity to the industry players. However, the US is expected to maintain its leading position as the world's largest IVD products market, growing at a moderate CAGR of 6.3% during 2014-2020.

Our segment-level analysis showed that the immunoassay market accounted for the largest market share of the total IVD products market. Although the segment is expected to witness a slow growth in the future due to competition from alternative technologies, especially molecular diagnostics, it is likely to sustain its topmost position in the market by 2020. Considering the growth rates, the market for molecular diagnostic IVD products is anticipated to outpace all the other segments, owing to selectivity, sensitivity, speed, accuracy, cost-effectiveness and breadth of application advantages over alternative IVDs.

Our report has been authored to evaluate the US diagnostic market potentials, and identify future growth opportunities. It provides extensive research and analysis on current market trends and future forecasts on all prominent diagnostic techniques including medical imaging and in vitro diagnostics.

The report also provides an insight into the market consolidation over the past few years, the competitive landscape of both the diagnostics and lab services market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving US diagnostic market.

Table Of Contents

US Diagnostic Market Outlook 2020
1. Analyst View
2. Research Methodology
3. Emerging Market Trends and Drivers
3.1 Diagnostics: Heading Towards Diversified Applications
3.2 Cancer Diagnostics: Key Focus Area for Industry Players
3.3 Patient Monitoring: Benefiting from Diagnostic Advancements
3.4 Improving Life Expectancy: Stimulating Diagnostic Market
3.5 Molecular Diagnostics: Future of Disease Diagnosis
3.6 Personalized Medicine: Revolutionizing Diagnostics
4. Industry Overview
4.1 Medical Imaging Equipments
4.1.1 Magnetic Resonance Imaging
4.1.2 Ultrasound
4.1.3 Computed Tomography (CT) Scanners
4.1.4 X-Ray Systems
4.2 IVD Products
4.2.1 Immunoassay
4.2.2 Clinical Chemistry
4.2.3 Blood Testing
4.2.4 Molecular Diagnostics
4.3 Segmentation by Indication
4.3.1 Diabetes
4.3.2 Cardiovascular
4.3.3 Cancer
4.3.4 HIV
5. Clinical Lab Services Market
6. Market Consolidations
7. Competitive Landscape
7.1 By Diagnostic Products
7.1.1 Roche Holding Ltd.
7.1.2 Johnson and Johnson
7.1.3 BioMerieux S.A.
7.1.4 Siemens AG
7.1.5 Becton Dickinson
7.1.6 Abbott Laboratories
7.1.7 Beckman Coulter Inc.
7.1.8 Hologic Inc.
7.1.9 QIAGEN
7.1.10 Thermo Fisher Scientific Inc.
7.2 By Services
7.2.1 Quest Diagnostics Inc.
7.2.2 Laboratory Corporation of America Holdings
7.2.3 Genomic Health Inc.

List of Figures:

Figure 3-1: Patient Monitoring System Demand (Billion US$), 2014-2020
Figure 4-1: Medical Imaging Market Segmentation by Products (%), 2014
Figure 4-2: Medical Imaging Market Segmentation by Products (%), 2020
Figure 4-3: Medical Imaging Market (Billion US$), 2014-2020
Figure 4-4: Magnetic Resonance Imaging Market (Billion US$), 2014-2020
Figure 4-5: Ultrasound Imaging Market (Billion US$), 2014-2020
Figure 4-6: Computed Tomography (CT) Scanners Market (Billion US$), 2014-2020
Figure 4-7: X-Ray Systems Market (Billion US$), 2014-2020
Figure 4-8: IVD Products Market (Billion US$), 2014-2020
Figure 4-9: IVD Products Market by Clinical Segment (%), 2014
Figure 4-10: IVD Products Market by Clinical Segment (%), 2020
Figure 4-11: Immunoassay Diagnostics Market (Billion US$), 2014-2020
Figure 4-12: Clinical Chemistry Market (Billion US$), 2014-2020
Figure 4-13: Blood Testing Market (Billion US$), 2014-2020
Figure 4-14: Molecular Diagnostics Market (Billion US$), 2014-2020
Figure 4-15: Number of Diabetics in the US (Million), 2014 and 2030
Figure 4-16: Blood Glucose Monitoring Systems Market (Billion US$), 2014-2020
Figure 4-17: Cardiovascular Diagnostics Market (Billion US$), 2014-2020
Figure 4-18: Cancer Diagnostics Market (Billion US$), 2014-2020
Figure 5-1: Breakup of Clinical Lab Market by Services (%), 2014
Figure 5-2: Breakup of Outside Hospital Lab Services (%), 2014
Figure 5-3: Clinical Lab Services Market (Billion US$), 2014-2020

List of Tables:

Table 3-1: Life Expectancy and Prevalence of Diseases by Countries
Table 4-1: List of HIV Diagnostic Products
Table 6-1: Recent MandA in the US Diagnostics Market (2012 - 2015)
Table 7-1: Roche Holding Ltd. - Revenue by Business Segments (Million CHF), 2013 and 2014
Table 7-2: Roche Holding Ltd. - Strengths and Weaknesses
Table 7-3: Johnson and Johnson - Breakup of Medical Device Business (Million US$), 2013 and 2014
Table 7-4: Johnson and Johnson - Strengths and Weaknesses
Table 7-5: BioMerieux S.A. - Revenue by Business Segments (Million Euros), 2013 and 2014
Table 7-6: BioMerieux S.A. - Strengths and Weaknesses
Table 7-7: Siemens AG - Strengths and Weaknesses
Table 7-8: Becton Dickinson - Revenue by Business Segments (Million US$), 2013 and 2014
Table 7-9: Becton Dickinson - Strengths and Weaknesses
Table 7-10: Abbott Laboratories - Revenue by Business Segments (Million US$), 2013 and 2014
Table 7-11: Abbott Laboratories - Strengths and Weaknesses
Table 7-12: Beckman Coulter Inc. - Strengths and Weaknesses
Table 7-13: Hologic Inc. - Revenue by Business Segments (Million US$), 2013 and 2014
Table 7-14: Hologic Inc. - Strengths and Weaknesses
Table 7-15: QIAGEN - Strengths and Weaknesses
Table 7-16: Thermo Fisher Scientific Inc. - Revenue by Business Segments (Million US$), 2013 and 2014
Table 7-17: Thermo Fisher Scientific Inc. - Strengths and Weaknesses
Table 7-18: Quest Diagnostics Inc. - Strengths and Weaknesses
Table 7-19: Laboratory Corporation of America Holdings - Strengths and Weaknesses
Table 7-20: Genomic Health Inc. - Strengths and Weaknesses

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.